Suppr超能文献

携带或重排的前期/微创肺腺癌的临床特征及进展:一项回顾性队列研究

Clinical characteristics and progression of pre-/minimally invasive lung adenocarcinoma harboring or rearrangements: a retrospective cohort study.

作者信息

Deng Chaoqiang, Chen Zongwei, Bai Jinsong, Fu Fangqiu, Wang Shengping, Li Yuan, Zhang Yang, Chen Haiquan

机构信息

Department of Thoracic Surgery and State Key Laboratory of Genetic Engineering, Fudan University Shanghai Cancer Center, Shanghai, China.

Institute of Thoracic Oncology, Fudan University, Shanghai, China.

出版信息

Transl Lung Cancer Res. 2023 Dec 26;12(12):2440-2447. doi: 10.21037/tlcr-23-517. Epub 2023 Dec 22.

Abstract

BACKGROUND

Patients harboring anaplastic lymphoma kinase () or rearranged during transfection () rearrangements are usually diagnosed at a relatively late stage with nodal and distant metastasis, and rapid progression course of / fusion-positive lung cancer were well-known. However, clinical characteristics and course of pre-/minimally invasive lung adenocarcinoma harboring or fusions are poorly described. Identifying patients with gene fusions at early stage may offer surgical options that could cure those patients.

METHODS

We retrospectively included patients with surgically resected pre-/minimally invasive lung adenocarcinomas harboring epidermal growth factor receptor () mutations or / rearrangements, and further compared the patient clinical characteristics, nodule natural course, and survival outcomes. Radiological characteristics including ground-glass component, cystic airspace, pleural attachment, etc. were specially assessed for this study. (exons 18-22) was detected by Sanger sequencing and quantitative real-time polymerase chain reaction (qRT-PCR) was used to analyze the / rearrangements. Lung cancer-specific survival (LCSS), relapse-free survival (RFS), and overall survival (OS) were all evaluated.

RESULTS

Of 238 patients with pre-/minimally invasive lung adenocarcinomas, 226 patients had mutations, 7 patients had fusions, and 5 patients had fusions. Average age at surgery was 45.3 years for /-positive group and 52.6 years for -positive group (P=0.049). Radiologically, among the 12 patients with / fusions, the majority of lesions (10/12) manifested as mixed ground-glass opacities (mGGOs), which was significantly more prevalent when compared with patients with mutations (83.4% 24.3%, P<0.001). Moreover, a substantial proportion of cystic airspace was found in /-positive group but not in -positive group (66.7% 14.2%, P<0.001). Among four patients with / fusions undergoing surveillance over 1 year before surgery, two of them developed rapid radiologic progression. The 5-year LCSS and RFS were 100%, 100% for /-positive group, and 100%, 100% for -positive group, respectively.

CONCLUSIONS

/-positive pre-/minimally invasive lung adenocarcinomas were mostly characterized as mGGOs with cystic airspace developing rapid nodule progression, and no recurrence occurred during long-term follow-up after resection. This provides insights into proper curative surgery timing in the management of patients with gene fusions. However, these findings must be treated with caution and validated in future multi-center studies with larger sample size.

摘要

背景

携带间变性淋巴瘤激酶(ALK)或转染期间重排(RET)重排的患者通常在疾病相对晚期被诊断出来,伴有淋巴结和远处转移,且ALK/RET融合阳性肺癌的病程进展迅速,这是众所周知的。然而,关于携带ALK或RET融合的原位/微浸润性肺腺癌的临床特征和病程描述较少。早期识别基因融合患者可能提供可治愈这些患者的手术选择。

方法

我们回顾性纳入了接受手术切除的原位/微浸润性肺腺癌患者,这些患者携带表皮生长因子受体(EGFR)突变或ALK/RET重排,并进一步比较了患者的临床特征、结节自然病程和生存结局。本研究特别评估了包括磨玻璃成分、囊状气腔、胸膜附着等在内的影像学特征。通过桑格测序检测EGFR(外显子18 - 22),并使用定量实时聚合酶链反应(qRT-PCR)分析ALK/RET重排。评估肺癌特异性生存(LCSS)、无复发生存(RFS)和总生存(OS)。

结果

在238例原位/微浸润性肺腺癌患者中,226例患者有EGFR突变,7例患者有ALK融合,5例患者有RET融合。ALK/RET阳性组的平均手术年龄为45.3岁,EGFR阳性组为52.6岁(P = 0.049)。在影像学上,在12例ALK/RET融合患者中,大多数病变(10/12)表现为混合磨玻璃影(mGGOs),与EGFR突变患者相比,其发生率显著更高(83.4%对24.3%,P < 0.001)。此外,ALK/RET阳性组发现相当比例的囊状气腔,而EGFR阳性组未发现(66.7%对14.2%,P < 0.001)。在手术前接受超过1年监测的4例ALK/RET融合患者中,其中2例出现快速的影像学进展。ALK/RET阳性组的5年LCSS和RFS分别为100%、100%,EGFR阳性组为100%和100%。

结论

ALK/RET阳性原位/微浸润性肺腺癌大多表现为伴有囊状气腔的mGGOs,结节进展迅速,切除后长期随访未发生复发。这为基因融合患者的适当根治性手术时机提供了见解。然而,这些发现必须谨慎对待,并在未来更大样本量的多中心研究中进行验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fef4/10775003/adab7f10da6a/tlcr-12-12-2440-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验